Pfizer deal lifts Human Genome.(BUSINESS)(YOUR MONEY: STOCK VIEW) From: The Washington Times | Date: December 23, 2003 | COPYRIGHT 2003 News World Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Byline: Marguerite Higgins, THE WASHINGTON TIMES

Shares of Human Genome Sciences Inc. rallied yesterday after the Rockville pharmaceutical company announced a deal with pharmaceutical giant Pfizer Inc.

Pfizer last week bought from Human Genome its rights for research, development and marketing of products based on gene sequences from Staphylococcus aureus, a spherical bacterium that causes a wide range of hospital infections.

The deal amends a 1996...